This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Young-McCaughan, S. Articles by Bertram, K. A. Search for Related Content PubMed PubMed Citation Articles by Young-McCaughan, S. Articles by Bertram, K. A.

The Department of Defense Congressionally Directed Medical Research Program

Innovations in the Federal Funding of Biomedical Research^{1 ,,2}

United States Army Medical Research and Materiel Command, Congressionally Directed Medical Research Programs, Fort Detrick, Maryland 21702-5024

ABSTRACT

In response to the lobbying efforts of the women’s advocacymovement, in 1993 Congress authorized funds for a substantialincrease in support of new and promising researchaimed at the eradication of breast cancer. This appropriationresulted in a major expansion of the United StatesArmy Medical Research and Materiel Command, Department of Defense Breast Cancer Research Program. The Office of Congressionally Directed Medical Research Programs was established within the United States Army Medical Research and Materiel Command to facilitate the management of the expanded extramural research program. Since that time, the programs have grown to include not just breast cancer but also prostate cancer, ovarian cancer, and neurofibromatosis. The unique appropriations to the Office of Congressionally Directed Medical Research Programs has resulted in a number of programmatic innovations. These include development of unique mechanisms of grant support, inclusion of consumer advocates on peer and programmatic review panels, and the introduction of criteria-based evaluation and scoring in peer review. This article describes these novel scientific management strategies and outlines their success in meeting program visions and goals.

This article has been cited by other articles:

				M. W. Foster, J. J. Mulvihill, and R. R. Sharp Investments in Cancer Genomics: Who Benefits and Who Decides Am J Public Health, November 1, 2006; 96(11): 1960 - 1964. [Abstract] [Full Text] [PDF]